Deals

CROs & CMOs ×
Aug 2021
has been acquired by
an Odyssey Investment Partners-backed company
May 2021
has been acquired by
a Behrman Capital-backed company
Feb 2021
has been acquired by
Jan 2021
has invested in
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to
Oct 2020
has been acquired by
a Gilde Healthcare-backed company
Oct 2020
has divested its Poznań, Poland manufacturing site to
Sep 2020
has divested its Barcelona manufacturing sites to
Sep 2020
has divested its Segré, France manufacturing facility to
Mar 2020
has divested its Mississauga, Ontario manufacturing facility to
Feb 2019
has acquired
Jul 2018
a Sovereign Capital Partners investment
has been acquired by
a Linden Capital Partners LLC investment
Jun 2018
has divested its Holmes Chapel manufacturing site to
Feb 2018
has divested the global rights to LEUKINE® and associated manufacturing assets to
May 2017
has signed a definitive merger agreement with